Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-41.71	189.33	324.81
Graham Fair Price	50.28	1.84	1.23
PEG	-76.31	0.65	-2.76
Price/Book	-10.59	1.88	2.11
Price/Cash Flow	144.03	721.12	-295.51
Prices/Earnings	-60.51	82.33	208.46
Price/Sales	-9.64	9.84	10.89
Price/FCF	144.03	721.12	-295.51
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	8.97	0.08	0.07
Operating Margin	57.40	0.04	0.02
ROA	125.10	< 0.005	< 0.005
ROE	< 0.005	< 0.005	126.38
ROIC	< 0.005	< 0.005	87.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.01	< 0.005	-59.66
Dividends QOQ	-0.17	-0.17	2.36
EBIT QOQ	-0.72	0.55	-22.59
EPS QOQ	-0.76	1.26	66.75
FCF QOQ	-1.16	1.37	17.75
Revenue QOQ	-0.19	-0.01	93.33
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.89	7.95	35.10
Days Sales Outstanding (DSO)	17.13	11.22	-34.47
Inventory Turnover	15.28	11.31	-25.98
Debt/Capitalization	< 0.005	< 0.005	-1.14
Quick Ratio	12.49	8.42	-32.58
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	5.14	5.15	0.06
Cash	2.08	1.77	-14.62
Capex	< 0.005	< 0.005	-65.39
Free Cash Flow	-0.04	0.01	-63.41
Revenue	0.99	0.98	-1.17
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	12.92	8.73	-32.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-62.43	-33.33	46.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating